Vicore Pharma Holding AB (publ) (STO:VICO)
10.80
-0.30 (-2.70%)
Jan 21, 2026, 12:48 PM CET
Vicore Pharma Holding AB Revenue
Vicore Pharma Holding AB had revenue of 760.00K SEK in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 8.50M, down -91.85% year-over-year. In the year 2024, Vicore Pharma Holding AB had annual revenue of 109.35M.
Revenue (ttm)
8.50M
Revenue Growth
-91.85%
P/S Ratio
367.60
Revenue / Employee
236.14K
Employees
29
Market Cap
3.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 109.35M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Saniona AB | 743.21M |
| BioInvent International AB | 244.85M |
| Hansa Biopharma AB | 178.61M |
| Genovis AB (publ.) | 117.66M |
| Oncopeptides AB | 62.47M |
| Egetis Therapeutics AB | 55.40M |
| Xspray Pharma AB | 3.81M |
| Flerie AB | 2.50M |